| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 01/29/2004 | US20040019216 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 01/29/2004 | US20040019106 Cyano and carboxy derivatives of substituted styrenes; inhibitors of tumor necrosis factor alpha, nuclear factor kappa B, and phosphodiesterase |
| 01/29/2004 | US20040019100 HMG CoA-reductase inhibitors |
| 01/29/2004 | US20040019094 N-imine guanidine compounds; treatment of obesity, anorexia, inflammation and mental disorders |
| 01/29/2004 | US20040019083 Amino acid derivatives; antineoplastic agents |
| 01/29/2004 | US20040019061 1-H-3-arylpirrolidine-2,4-dione derivatives |
| 01/29/2004 | US20040019033 Mandelic acid derivatives and their use as throbin inhibitors |
| 01/29/2004 | US20040018532 Electronic sensor device |
| 01/29/2004 | CA2493457A1 Acetylamino benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 01/29/2004 | CA2493339A1 2-cyano-4-fluoropyrrolidine derivative or salt thereof |
| 01/29/2004 | CA2492906A1 Materials and methods for treating hypercholesterolemia |
| 01/28/2004 | EP1384719A1 Inhibitors of the glucosyl ceramide synthase enzyme useful for the treatment of cancers, sphingolipidosis and microbial infections |
| 01/28/2004 | EP1383760A1 Biarylcarboxamide compounds as apolipoprotein b inhibitors |
| 01/28/2004 | EP1383748A2 Novel compounds and compositions as cathepsin inhibitors |
| 01/28/2004 | EP1383736A2 Peptide deformylase inhibitors |
| 01/28/2004 | EP1383731A1 Biaryl compounds as serine protease inhibitors |
| 01/28/2004 | EP1383729A1 Peptide deformylase inhibitors |
| 01/28/2004 | CN1471511A Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases |
| 01/27/2004 | US6683215 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 01/27/2004 | US6683201 Analine derivatives as OSC inhibitors |
| 01/27/2004 | US6683189 Method for the synthesis of pyrrole and imidazole carboxamides on a solid support |
| 01/27/2004 | US6683104 Cholesterol and triglyceride-modulating drugs and methods |
| 01/27/2004 | US6683099 Substituted N,N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 01/27/2004 | US6683078 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 01/27/2004 | US6683074 Cyclic amine derivatives-CCR-3 receptor antagonists |
| 01/27/2004 | US6682782 Organic compound having an acetylene group, vacuum deposition polymerization thereof, deposited polymerized thin film, and electroluminescence device containing same |
| 01/27/2004 | CA2214720C Arylsulfonylamino hydroxamic acid derivatives |
| 01/27/2004 | CA2213007C Stereoselective ring opening reactions |
| 01/22/2004 | WO2004007449A1 Process for conversion of phenols to carboxamides via the succinimide esters |
| 01/22/2004 | WO2004007448A1 Cis-alkoxy-substituted spirocyclic 1-h-pyrrolidine-2,4-dione derivatives serving as pesticides |
| 01/22/2004 | WO2004007447A1 Squarylium compound, metal complex thereof, and organic el element containing these |
| 01/22/2004 | WO2004007445A2 Protein kinase c modulators, and methods of use thereof |
| 01/22/2004 | WO2004007444A2 N-hydroxyamide derivatives possessing antibacterial activity |
| 01/22/2004 | WO2004007407A2 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof |
| 01/22/2004 | WO2004006923A1 Aryl piperidine derivatives as inducers of ldl-receptor expression for the treatment of hypercholesterolemia |
| 01/22/2004 | WO2004006920A1 Topical treatment of skin diseases |
| 01/22/2004 | WO2004006878A1 Merocyanine derivatives for cosmetic use |
| 01/22/2004 | WO2003080545A3 Substituted phenylacetic acids |
| 01/22/2004 | WO2003074990A9 Artificial receptors, building blocks, and methods |
| 01/22/2004 | WO2002070464A3 Hydrazones and their therapeutic use |
| 01/22/2004 | US20040014984 Amination by reducing the nitro group on pyrrole ring, amidation with a blocking group on the 4-amino group; useful as peptide, use in nucleotide sequence recognition |
| 01/22/2004 | US20040014980 Process and intermediates |
| 01/22/2004 | US20040014801 Thio semicarbazone and semicarbazone inhibitors of cysteine proteases and methods of their use |
| 01/22/2004 | US20040014762 Pyrrolopyridazine compounds |
| 01/22/2004 | US20040014758 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 01/22/2004 | DE10231333A1 Cis-Alkoxysubstituierte spirocyclische 1-H-Pyrrolidin-2,4-dion-Derivate Cis-alkoxy-substituted spirocyclic 1-H-pyrrolidine-2,4-dione derivatives |
| 01/22/2004 | DE10228132A1 Amide cyclischer Aminosäuren als PDE 4 Inhibitoren Amides of cyclic amino acids as PDE 4 inhibitors |
| 01/22/2004 | CA2492093A1 Topical treatment of skin diseases |
| 01/21/2004 | EP1381668A1 Compounds, compositions, and methods for controlling biofilms |
| 01/21/2004 | EP1381590A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 01/21/2004 | EP1381462A1 Polymer-bound catalyst for the enantioselective aldol or mannich reaction |
| 01/21/2004 | EP0981366B1 Selective mmp inhibitors having reduced side-effects |
| 01/21/2004 | EP0787009B1 Cancer inhibitory peptides |
| 01/20/2004 | US6680336 Cyclic nucleotide phosphodiesterases inhibitors; antiinflammatory agents; 2,3-dioxy-4-pyrrole substituted phenyl derivatives |
| 01/20/2004 | US6680317 N-(phenyl)-n*-(2-hydroxy-3-aminosulfonylphenyl)guanidine derivatives; chemokine inhibitors; respiratory, cardiovascular, rheumatic, brain, and nervous system disorders |
| 01/20/2004 | US6680283 Fungicidal compositions comprising as active compounds pyrrolidones, and their use in the treatment of plants |
| 01/20/2004 | US6679663 Locking nut, bolt and clip systems and assemblies |
| 01/15/2004 | WO2004005981A1 Filters for electronic displays |
| 01/15/2004 | WO2004005392A2 Maleimidopropyl trimethoxysilane and related free-radically polymerizable coupling agents as adhesion promotors in adhesive formulations |
| 01/15/2004 | WO2004005278A1 Bisarylsulfonamide compounds and their use in cancer therapy |
| 01/15/2004 | WO2004005255A1 N-benzyl-3-phenyl-3-heterocyclyl-propionamide compounds as tachykinin and/ or serotonin reuptake inhibitors |
| 01/15/2004 | WO2004005250A1 Hmg-coa reductase inhibitors |
| 01/15/2004 | WO2004005249A1 Pyrrolidine derivatives as oxytocin antagonists |
| 01/15/2004 | WO2004005248A1 Peptide inhibitors of smac protein binding to inhibitor of apoptosis proteins (iap) |
| 01/15/2004 | WO2004004657A2 Hiv integrase inhibitors |
| 01/15/2004 | WO2002055025A3 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (bvdv) infection and hepatitis c virus (hcv) infection |
| 01/15/2004 | US20040010159 Blends of quinone alkide and nitroxyl compounds and polymerization inhibitors |
| 01/15/2004 | US20040010139 Using iridium complex as hydrogenation catalyst |
| 01/15/2004 | US20040010031 3-aminomaleimide derivatives used for treatment and/or prophylaxis of mood disorders, schizophrenia, neurotraumatic diseases, cancer or hair-loss. |
| 01/15/2004 | US20040010030 Novel anti-infectives |
| 01/15/2004 | US20040010009 Excellent inhibitory activity against factor Xa |
| 01/15/2004 | US20040009979 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 01/15/2004 | US20040009969 Diazacycloalkanes containing a 2,5-dioxo-1H-pyrrolyl- or 4-oxo-2-thioxoimidazolidinyl- groups; treating prostate cancer, benign prostate hyperplasia, androgenetic alopecia, hirsutism and androgen-dependent acne. |
| 01/15/2004 | CA2492162A1 Hmg-coa reductase inhibitors |
| 01/15/2004 | CA2492035A1 N-hydroxyamide derivatives possessing antibacterial activity |
| 01/15/2004 | CA2491041A1 Peptide inhibitors of smac protein binding to inhibitor of apoptosis proteins (iap) |
| 01/15/2004 | CA2488816A1 Bisarylsulfonamide compounds and their use in cancer therapy |
| 01/14/2004 | EP1379676A2 Process for the preparation of 2-hydroxymethyl-pyrolidine-3,4-diols |
| 01/14/2004 | EP1379521A1 Delta1-pyrrolines |
| 01/14/2004 | EP1379519A1 Pyrrolidine sulfonamides |
| 01/14/2004 | EP1379500A2 METHOD FOR THE PRODUCTION OF $g(D)?1 PYRROLINES |
| 01/14/2004 | EP1379498A1 Sulphones which modulate the action of gamma secretase |
| 01/14/2004 | EP1379493A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses |
| 01/14/2004 | EP1379237A2 Pyrrolidine sulfonamides |
| 01/14/2004 | EP1379236A1 Treatment of tics, tremors and related disorders |
| 01/14/2004 | CN1468227A Non-imidazole aryloxyalkylamines |
| 01/14/2004 | CN1468226A Biphenyl derivatives and their use as ppar-gamma receptor activators |
| 01/14/2004 | CN1468221A Non-imidazole aryloxypiperidines |
| 01/14/2004 | CN1468217A Aliphatic nitrogenous five-membered ring compounds |
| 01/14/2004 | CN1468216A Nitrogenous five-membered ring compounds |
| 01/14/2004 | CN1468214A Novel derivatives of aminocyclohexane |
| 01/14/2004 | CN1468211A Nitroso diphenylamine derivatives |
| 01/14/2004 | CN1468207A New retinoids for the treatment of emphysema |
| 01/14/2004 | CN1468099A Antitumor therapy comprising distamycin derivatives |
| 01/14/2004 | CN1467205A Method for preparing CYCLOHEXANE maleimide |
| 01/14/2004 | CN1134457C New alpha-aminoacetophenone photoinitiators |
| 01/14/2004 | CN1134423C Adhesion receptor antagonists |
| 01/14/2004 | CN1134414C Substituted oximes, hydrazones and olefins as neurokinin antagonists |
| 01/14/2004 | CN1134413C Sulfonyl pyrrolidone containing compound and its preparation and pharmaceutical application |
| 01/14/2004 | CN1134412C N-substituted 2-cyanopyrodlidines |